logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Adam Robert Dorfman

This inventor holds 5 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Clene Nanomedicine, Inc, a Nevada Corporation, Clene Nanomedicine, Inc., Gr Intellectual Reserve, LLC, a Nevada LLC. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam Robert Dorfman. Retrieved from https://idiyas.com/inventor/adam-robert-dorfman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Clene Nanomedicine, Inc, a Nevada Corporation
 patent
silverMedal1 out of 5 
 
Clene Nanomedicine, Inc.
 patents
bronzeMedal1 out of 1 
 
Gr Intellectual Reserve, LLC, a Nevada LLC
 patent
4. 1 out of 20 
 
Grintellectual Reserve, LLC
 patents
5. 1 out of 834,513 
Other
 patents

Years Active: 2015-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11007573 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2021-05-18),
2. 10035192 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g.,nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2018-07-31),
3. 9603870 - Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor (2017-03-28),
4. 9387225 - Gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same (2016-07-12),
5. 9067263 - Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom (2015-06-30),

Title: Adam Robert Dorfman: Innovator in Nanoparticle Manufacturing

Introduction

Adam Robert Dorfman is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of nanoparticle manufacturing, holding a total of 5 patents. His work focuses on innovative methods for treating liquids and creating nanoparticles, which have various applications in science and technology.

Latest Patents

Dorfman's latest patents include groundbreaking inventions related to continuous, semicontinuous, and batch methods for treating liquids and manufacturing nanoparticles. These inventions involve novel methods and devices for the continuous production of nanoparticles and microparticles in liquid solutions. The processes utilize adjustable plasma and electrochemical techniques to create nanoparticles with unique properties, such as size, shape, and composition. The results of his inventions include the formation of ions and metallic-based nanoparticles in liquids, which can be used in various applications.

Career Highlights

Throughout his career, Adam Robert Dorfman has worked with Clene Nanomedicine, Inc., a company focused on nanomedicine and innovative treatments. His expertise in nanoparticle technology has positioned him as a leader in this emerging field.

Collaborations

Dorfman has collaborated with notable professionals in the industry, including Mark Gordon Mortenson and David Andrew Bryce. These collaborations have further enhanced his research and development efforts in nanoparticle manufacturing.

Conclusion

Adam Robert Dorfman's contributions to the field of nanoparticle manufacturing demonstrate his innovative spirit and commitment to advancing technology. His patents and career achievements reflect his significant impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…